It is a pharma private limited company based in Punjab, Punjab, India, established in 1999.
1999 | Punjab, Punjab, India | Struck OffSefal Pharmaceutics Private Limited, a struck off private limited company, was established on 10 March 1999 in Punjab, Punjab, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232PB1999PTC022320. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.45 M.
It upholds a compliant status. Its leadership includes Shaheer Zaman Ariz (Director), Yashpal Arora (Director). Past directors included Rajesh Kumar Sharma, Sunita Sharma, Tarun Kumar Dawar. It holds no open charges and ₹0.80 M settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 1 A 169 Janta Nagarm K Road Dhuri Distt Sangrur, Punjab, Punjab, 148024.
U24232PB1999PTC022320
022320
10 March 1999
₹1.50 M
₹1.45 M
Roc Chandigarh
Unlisted
Struck Off
Explore comprehensive insights into Sefal Pharmaceutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shaheer Zaman Ariz | Director | 22 Sep 2014 | Current |
| Yashpal Arora | Director | 22 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 15 Oct 2014 | Past |
| Pramod Abcsdd | Director | 20 May 2011 | Past |
| Pramod Abcsdd | Director | 15 Oct 2014 | Past |
| Pramod Abcsdd | Director | 15 Oct 2014 | Past |
| Pramod Abcsdd | Additional Director | 01 Oct 2014 | Past |
| Pramod Abcsdd | Additional Director | 01 Oct 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sefal Pharmaceutics Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 14608.92% increase. The company also saw a substantial fall in profitability, with a 2393.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Sefal Pharmaceutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2002 | Punjab National Bank | ₹0.80 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sefal Pharmaceutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sefal Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sefal Pharmaceutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sefal Pharmaceutics Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
The activity Sefal Pharmaceutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chandigarh. was completed.
Progress on A charge registered on 28 Oct 2002 via Charge ID 90176069 with Punjab National Bank was fully satisfied on 10 Jun 2015. was documented.
Progress on Shaheer Zaman Ariz was appointed as a Director was appointed as a Director on 22 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
Progress on Yashpal Arora was appointed as a Director was appointed as a Director on 22 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
A charge with Punjab National Bank amounted to Rs. 0.80 M with Charge ID 90176069 was registered on 28 Oct 2002. was recorded as a recent event.
The CIN of Sefal Pharmaceutics Private Limited is U24232PB1999PTC022320.
Sefal Pharmaceutics Private Limited is headquartered at 1 A 169 Janta Nagarm K Road Dhuri Distt Sangrur, Punjab, Punjab, 148024.
Sefal Pharmaceutics Private Limited was incorporated on 10 March 1999.
The current directors of Sefal Pharmaceutics Private Limited are
The primary industry of Sefal Pharmaceutics Private Limited is Trade.
Sefal Pharmaceutics Private Limited is unlisted.
The authorized capital of Sefal Pharmaceutics Private Limited is ₹1.50 M, and the paid-up capital is ₹1.45 M.
The compliance status of Sefal Pharmaceutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX